You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
| Title |
The role of bisphosphonates in breast cancer: The present and future role of bisphosphonates in the management of patients with breast cancer
|
|---|---|
| Published in |
Breast Cancer Research, December 2001
|
| DOI | 10.1186/bcr413 |
| Pubmed ID | |
| Authors |
Janet E Brown, Robert E Coleman |
| Abstract |
At least 25% of patients with breast cancer develop skeletal metastases, with bone the site of disease producing the greatest morbidity. It is apparent that the bisphosphonates present an important component of the treatment strategy. They are now the treatment of choice in tumour-induced hypercalcaemia, and they can reduce bone pain and skeletal complications such as pathological fractures. In addition, bisphosphonates are being increasingly evaluated in the prevention of bone metastases and to prevent and treat cancer therapy-induced osteoporosis. Ongoing research is aimed at trying to define the optimum route, dose, schedule and type of bisphosphonate. |
Mendeley readers
The data shown below were compiled from readership statistics for 20 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 5% |
| Unknown | 19 | 95% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Postgraduate | 5 | 25% |
| Student > Bachelor | 4 | 20% |
| Student > Ph. D. Student | 3 | 15% |
| Researcher | 2 | 10% |
| Other | 1 | 5% |
| Other | 1 | 5% |
| Unknown | 4 | 20% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 7 | 35% |
| Agricultural and Biological Sciences | 3 | 15% |
| Economics, Econometrics and Finance | 1 | 5% |
| Business, Management and Accounting | 1 | 5% |
| Decision Sciences | 1 | 5% |
| Other | 3 | 15% |
| Unknown | 4 | 20% |